Asceneuron
SwitzerlandEntry
2020
Hold
6yr
Status
Active
Who owns Asceneuron?
Asceneuron is currently owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage), since 2020. Across its history, Asceneuron has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Capital IX · 2018 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2020 · present
Sofinnova PartnersActive
2020 · present(6yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
Novo HoldingsActive
2024 · present(2yr) · Novo Holdings Venture Investments · 1999 · VC
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
US
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack Asceneuron
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Asceneuron?
4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Asceneuron.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue